Acanthosis Nigricans in Patients with Type II Diabetes Mellitus at a Tertiary Care Hospital of Lahore
DOI:
https://doi.org/10.51985/JBUMDC202266Keywords:
Acanthosis Nigricans, Insulin Resistance,Type II Diabetes Mellitus.Abstract
Objective: Acanthosis Nigricans is characterized by skin thickening with hyperpigmentation dermatosis predominantly
seen on flexural aspects & nape of neck. The objective of present study was to determine frequency of Acanthosis Nigricans
among patients of type II diabetes mellitus.
Study Design and Setting: This observational cross-sectional study was undertaken at Department of Medicine Azra
Naheed Medical College, Superior University Lahore from August 2021 to April 2022.
Methodology: Type II diabetes mellitus was defined as patients with HbA1c 7.0%, or two blood glucose random readings
of =200mg/dl, or previous history of diabetes diagnosis, or taking anti-hyperglycemic medicines. Acanthosis Nigricans
was defined as >2 cm poorly defined hyperpigmented skin lesions of brownish black color and velvety appearance present
over the nape of neck, axillae and/or groin. Patients with non-diabetic causes of Acanthosis Nigricans were excluded. After
informed consent, 340 patients of type II diabetes mellitus aged 30-75 years of both gender were enrolled using nonprobability consecutive sampling technique. Demographic information was noted and the patients were examined for
Acanthosis Nigricans. Data was entered and analyzed by SPSS version 20.0.
Results: Mean age was 48.2+13.8 years with 187 (55.0%) females. The mean height, weight and BMI were 1.5+0.3 meters,
57.8+11.6 kilograms and 28.8+9.5 kg/m2 respectively. The mean duration of disease was 44.2+9.3 months and Acanthosis
Nigricans was seen in 86 (25.2%). Acanthosis Nigricans was not significantly associated with age, gender, BMI or duration
of disease.
Conclusion: Acanthosis Nigricans was present in almost a quarter of type II diabetes mellitus patients.
References
Schmidt AM. Highlighting Diabetes Mellitus: The Epidemic
Continues. Arterioscler Thromb Vasc Biol. 2018;38(1):e1-e8.
doi: 10.1161/ATVBAHA.117.310221.
The Prevention of Diabetes Mellitus. JAMA. 2021;325(2):190.
doi: 10.1001/jama.2020.17738.
Das A, Datta D, Kassir M, Wollina U, Galadari H, Lotti T, et
al. Acanthosis Nigricans: A review. J Cosmet Dermatol.
;19(8):1857-1865. doi: 10.1111/jocd.13544.
Mendes AL, Miot HA, Haddad V Junior. Diabetes mellitus
and the skin. An Bras Dermatol. 2017;92(1):8-20. doi:
1590/abd1806-4841.20175514.
Sanches MM, Roda Â, Pimenta R, Filipe PL, Freitas JP.
Cutaneous Manifestations of Diabetes Mellitus and Prediabetes.
Acta Med Port. 2019;32(6):459-465. doi: 10.20344/amp.10738.
Litonjua P, Pinero-Pilona A, Aviles-Santa L, Raskin P.
Prevalence of Acanthosis Nigricans in newly-diagnosed type
diabetes. Endocr Pract. 2004;10(2):101-6.
Burke JP, Hale DE, Hazuda HP, Stern MP. A quantitative
scale of Acanthosis Nigricans. Diabetes Care.
;22(10):1655-9. doi: 10.2337/diacare.22.10.1655.
Grandhe NP, Bhansali A, Dogra S, Kumar B. Acanthosis
Nigricans: relation with type 2 diabetes mellitus,
anthropometric variables, and body mass in Indians. Postgrad
Med J. 2005; 81:541–544.
Harish MR, Shashikumar BM. Association of Dermatoses
with Diabetes- A Case Control Study. Webmed Central
Dermatology. 2012;3(4):WMC003280.
Wani MA, Hassan I, Bhat MH, Ahmed QM. Cutaneous
Manifestations of Diabetes mellitus: A Hospital Based Study
in Kashmir, India. Egyptian Dermatology Online Journal.
;5(2):1-6.
Khoharo HK, Ansari S, Qureshi F. Frequency of Skin
Manifestations in 120 Type 2 Diabetics Presenting at Tertiary
Care Hospital. J Liaquat Uni Med Health Sci. 2009;8(1):2-
WHO Expert Consultation. Appropriate body mass index for
Asian populations and its implications for policy and
intervention strategies. Lancet 2004; 363:157.
Niaz F, Bashir F, Shams N, Shaikh Z, Ahmed I. Cutaneous
manifestations of diabetes mellitus type 2: Prevalence and
association with glycemic control. J Pak Assoc Derma.
;26(1):4-11.
Ahmed K, Muhammad Z, Qayum I. Prevalence of cutaneous
manifestations of diabetes mellitus. J Ayub Med Coll
Abbottabad. 2009;21(2):76-9.
Deepika, Gupta SK, Singh P, Monika. Pattern of
dermatological diseases in patients of diabetes mellitus.
J Pak Assoc Derma. 2016;26(3):214-218.
Kobaissi HA, Weigensberg MJ, Ball GD, Cruz ML, Shaibi
GQ, Goran MI. Relation between Acanthosis Nigricans and
insulin sensitivity in overweight Hispanic children at risk for
type 2 diabetes. Diabetes Care. 2004 ;27(6):1412-6.
Stuart CA, Smith MM, Gilkison CR, Shaheb S, Stahn RM.
Acanthosis Nigricans among Native Americans: an indicator
of high diabetes risk. Am J Public Health. 1994;84(11):1839-
Patel NU, Roach C, Alinia H, Huang WW, Feldman SR.
Current treatment options for Acanthosis Nigricans. Clin
Cosmet Investig Dermatol. 2018;11:407-413.
Rao G, Chauhan YV, Varthakavi PK, Bhagwat N. A Lean
Lady With Acanthosis Nigricans and Uncontrolled Diabetes
M e l l i t u s . C u r e u s . 2 0 2 0 ; 1 2 ( 11 ) : e 11 3 3 0 . d o i :
7759/cureus.11330.
Lause M, Kamboj A, Fernandez Faith E. Dermatologic
manifestations of endocrine disorders. Transl Pediatr.
;6(4):300-312. doi: 10.21037/tp.2017.09.08.
Treesirichod A, Chaithirayanon S, Chaikul T, Chansakulporn
S. The randomized trials of 10% urea cream and 0.025%
tretinoin cream in the treatment of Acanthosis Nigricans. J
Dermatolog Treat. 2021;32(7):837-842. doi:
1080/09546634.2019.1708855.
Hines A, Alavi A, Davis MDP. Cutaneous Manifestations of
Diabetes. Med Clin North Am. 2021;105(4):681-697. doi:
1016/j.mcna.2021.04.008.
Tan SY, Mei Wong JL, Sim YJ, Wong SS, Mohamed-Elhassan
SA, Tan SH, et al. Type 1 and 2 diabetes mellitus: A review
on current treatment approach and gene therapy as potential
intervention. Diabetes Metab Syndr. 2019;13(1):364-372. doi:
1016/j.dsx.2018.10.008.
Wei JP, Wang QH, Zheng HJ, Wei F. Research Progress on
Non-Drug Treatment for Blood Glucose Control of Type 2
Diabetes Mellitus. Chin J Integr Med. 2018;24(10):723-727.
doi: 10.1007/s11655-018-2844-2
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Nauman Ismat Butt, Khalid Mahmood, Nimra Kanwal, Fahmina Ashfaq
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal of Bahria University Medical & Dental College is an open access journal and is licensed under CC BY-NC 4.0. which permits unrestricted non commercial use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc/4.0 
